Top Markets
Coin of the day
Tetra Bio-Pharma Inc. Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.

TBP
Pozycja w akcjach #35576
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Cena akcji
$0.01851783
Ostatnia synchronizacja: 2023-05-23
Kapitalizacja rynkowa
$3.71M
Zmiana (1 dzień)
-0.04%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel Tetra Bio-Pharma Inc. (TBP)

Kategoria

Historia ceny akcji dla Tetra Bio-Pharma Inc. (TBP)
Najwyższa cena zamknięcia: $0.02 dnia 2023-05-01

Najniższa cena zamknięcia: $0.47 dnia 2018-07-01
Historia cen akcji firmy Tetra Bio-Pharma Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 3.94%
2022 -84.88%
2021 -20.47%
2020 -60.18%
2019 -40.49%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE